Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently released a comprehensive report on the global preclinical imaging market. This report provides an in-depth evaluation of essential market dynamics, including key drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

Preclinical Imaging Market Size (2024E): US$4.3 Bn
Projected Market Value (2031F): US$5.96 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 4.55%

Preclinical Imaging Market - Report Scope:

Preclinical imaging is pivotal in the development of new drugs and therapies, allowing researchers to visualize and understand the effects of interventions at an early stage. The preclinical imaging market encompasses a range of imaging technologies, including MRI, PET, CT, and optical imaging systems. These technologies are employed in various research settings, including academic institutions, pharmaceutical companies, and contract research organizations (CROs), to support drug development, disease research, and therapeutic efficacy studies.

Market growth is driven by the increasing demand for advanced imaging techniques in research, rising investments in drug discovery, and technological advancements that enhance imaging resolution and accuracy. Additionally, the growing prevalence of chronic diseases and the need for personalized medicine further propel market expansion.

Market Growth Drivers:

Several key factors are driving the global preclinical imaging market. The rapid evolution of imaging technologies, such as the integration of high-resolution MRI and PET/CT systems, is significantly enhancing research capabilities. Increased investment in R&D by pharmaceutical and biotechnology companies is fueling demand for sophisticated imaging solutions to accelerate drug development processes. Moreover, the rise in chronic diseases and the need for personalized medicine are driving the adoption of advanced imaging technologies for precise disease modeling and therapeutic assessments.

Technological innovations, including advancements in molecular imaging and the development of multimodal imaging systems, are also contributing to market growth. These innovations improve the accuracy of preclinical studies and enable more detailed analysis of biological processes, supporting the advancement of new treatments and therapies.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces several challenges. The high cost associated with advanced imaging systems can limit their adoption, particularly among smaller research institutions and organizations in developing regions. Additionally, the complexity of imaging technologies and the need for specialized training can pose barriers to effective utilization. Regulatory constraints and the lengthy approval processes for new imaging technologies may also impact market dynamics.

Addressing these challenges requires ongoing efforts to reduce costs, enhance user training, and streamline regulatory pathways to facilitate broader access to advanced imaging solutions.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by technological advancements and increasing research activities. The development of portable and cost-effective imaging solutions, as well as the integration of AI and machine learning for data analysis, offers new avenues for market expansion. Furthermore, collaborations between research institutions, technology developers, and pharmaceutical companies are expected to drive innovation and accelerate the adoption of advanced imaging technologies.

The growing focus on personalized medicine and targeted therapies also opens up opportunities for the development of specialized imaging systems tailored to specific research needs. Strategic partnerships, investment in cutting-edge technologies, and expansion into emerging markets will be crucial for capitalizing on these opportunities and sustaining market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the preclinical imaging market globally?
Which imaging technologies and applications are gaining traction in preclinical research?
How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global preclinical imaging market, including Siemens Healthineers, GE Healthcare, and Bruker Corporation, are focusing on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging systems, such as high-resolution MRI and PET/CT scanners, and integrate cutting-edge technologies like AI for enhanced imaging capabilities. Collaborations with research institutions, pharmaceutical companies, and CROs facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practices, and user training is essential for driving market growth and advancing preclinical imaging capabilities.

Key Companies Profiled:

Bruker Corporation
Siemens A.G.
General Electric (GE)
TriFoil Imaging
PerkinElmer, Inc.
VisualSonics Inc. (Fujifilm)
Mediso Ltd.
Agilent Technologies
MILabs B.V.
MR Solutions
Molecubes

Preclinical Imaging Market Research Segmentation

By Product Type

Imaging Systems
Reagents

By Application

Research and Development
Drug Discovery

By End User

Pharmaceutical & Biotechnology Companies
Academic and research centres
Imaging Centres

By Region

North America
Europe
Asia Pacific
Latin America
The Middle East and Africa

Product Code: PMRREP34717

1. Executive Summary

1.1. Global Preclinical Imaging Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Industry Developments and Key Market Events
1.6. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Preclinical Imaging Market: Value Chain
- 2.3.1. List of key players
- 2.3.2. List of key distributors
2.4. Forecast Factors - Relevance and Impact
2.5. Covid-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter Five Force's Analysis

3. Key Regulations/ Standards

4. Price Trend Analysis, 2019-2031

4.1. Key Factors Impacting Prices
4.2. Prices by Source

5. Global Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

5.1. Market Size (US$ Bn) Analysis and Forecast
- 5.1.1. Historical Market Size Analysis, 2019-2023
- 5.1.2. Current Market Size Forecast, 2024-2031
5.2. Global Preclinical Imaging Market Outlook: Product Type
- 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 5.2.2.1. Imaging Systems
    - 5.2.2.1.1. Optical Imaging Systems
    - 5.2.2.1.2. Nuclear Imaging Systems
    - 5.2.2.1.3. Micro MRI Systems
    - 5.2.2.1.4. Micro Ultrasound Systems
    - 5.2.2.1.5. Micro CT Systems
    - 5.2.2.1.6. Photoacoustic Imaging Systems
    - 5.2.2.1.7. Magnetic Particle Imaging Systems
  - 5.2.2.2. Reagents
    - 5.2.2.2.1. Preclinical Optical Imaging Reagents
    - 5.2.2.2.2. Preclinical Nuclear Imaging Reagents
    - 5.2.2.2.3. Preclinical MRI Contrast Agents
    - 5.2.2.2.4. Preclinical CT Contrast Agents
    - 5.2.2.2.5. Software
- 5.2.3. Market Attractiveness Analysis: Product Type
5.3. Global Preclinical Imaging Market Outlook: Application
- 5.3.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 5.3.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 5.3.2.1. Research and Development
  - 5.3.2.2. Drug Discovery
- 5.3.3. Market Attractiveness Analysis: Application
5.4. Global Preclinical Imaging Market Outlook: End-user
- 5.4.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 5.4.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 5.4.2.1. Pharmaceutical & Biotechnology Companies
  - 5.4.2.2. Academic and research centres
  - 5.4.2.3. Imaging Centres
  - 5.4.2.4. Other End-users
- 5.4.3. Market Attractiveness Analysis: End-user

6. Global Preclinical Imaging Market Outlook: Region

6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
6.2. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
- 6.2.1. North America
- 6.2.2. Europe
- 6.2.3. East Asia
- 6.2.4. South Asia and Oceania
- 6.2.5. Latin America
- 6.2.6. Middle East & Africa
6.3. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 7.1.1. By Country
- 7.1.2. By Product Type
- 7.1.3. By Application
- 7.1.4. By End-user
7.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 7.2.1. U.S.
- 7.2.2. Canada
7.3. North America Preclinical Imaging Market Outlook: Product Type
- 7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 7.3.2.1. Imaging Systems
    - 7.3.2.1.1. Optical Imaging Systems
    - 7.3.2.1.2. Nuclear Imaging Systems
    - 7.3.2.1.3. Micro MRI Systems
    - 7.3.2.1.4. Micro Ultrasound Systems
    - 7.3.2.1.5. Micro CT Systems
    - 7.3.2.1.6. Photoacoustic Imaging Systems
    - 7.3.2.1.7. Magnetic Particle Imaging Systems
  - 7.3.2.2. Reagents
    - 7.3.2.2.1. Preclinical Optical Imaging Reagents
    - 7.3.2.2.2. Preclinical Nuclear Imaging Reagents
    - 7.3.2.2.3. Preclinical MRI Contrast Agents
    - 7.3.2.2.4. Preclinical CT Contrast Agents
    - 7.3.2.2.5. Software
7.4. North America Preclinical Imaging Market Outlook: Application
- 7.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 7.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 7.4.2.1. Research and Development
  - 7.4.2.2. Drug Discovery
7.5. North America Preclinical Imaging Market Outlook: End-user
- 7.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 7.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 7.5.2.1. Pharmaceutical & Biotechnology Companies
  - 7.5.2.2. Academic and research centres
  - 7.5.2.3. Imaging Centres
  - 7.5.2.4. Other End-users
7.6. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 8.1.1. By Country
- 8.1.2. By Product Type
- 8.1.3. By Application
- 8.1.4. By End-user
8.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 8.2.1. Germany
- 8.2.2. France
- 8.2.3. U.K.
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
8.3. Europe Preclinical Imaging Market Outlook: Product Type
- 8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 8.3.2.1. Imaging Systems
    - 8.3.2.1.1. Optical Imaging Systems
    - 8.3.2.1.2. Nuclear Imaging Systems
    - 8.3.2.1.3. Micro MRI Systems
    - 8.3.2.1.4. Micro Ultrasound Systems
    - 8.3.2.1.5. Micro CT Systems
    - 8.3.2.1.6. Photoacoustic Imaging Systems
    - 8.3.2.1.7. Magnetic Particle Imaging Systems
  - 8.3.2.2. Reagents
    - 8.3.2.2.1. Preclinical Optical Imaging Reagents
    - 8.3.2.2.2. Preclinical Nuclear Imaging Reagents
    - 8.3.2.2.3. Preclinical MRI Contrast Agents
    - 8.3.2.2.4. Preclinical CT Contrast Agents
    - 8.3.2.2.5. Software
8.4. Europe Preclinical Imaging Market Outlook: Application
- 8.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 8.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 8.4.2.1. Research and Development
  - 8.4.2.2. Drug Discovery
8.5. Europe Preclinical Imaging Market Outlook: End-user
- 8.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 8.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 8.5.2.1. Pharmaceutical & Biotechnology Companies
  - 8.5.2.2. Academic and research centres
  - 8.5.2.3. Imaging Centres
  - 8.5.2.4. Other End-users
8.6. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 9.1.1. By Country
- 9.1.2. By Product Type
- 9.1.3. By Application
- 9.1.4. By End-user
9.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 9.2.1. China
- 9.2.2. Japan
- 9.2.3. South Korea
9.3. East Asia Preclinical Imaging Market Outlook: Product Type
- 9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 9.3.2.1. Imaging Systems
    - 9.3.2.1.1. Optical Imaging Systems
    - 9.3.2.1.2. Nuclear Imaging Systems
    - 9.3.2.1.3. Micro MRI Systems
    - 9.3.2.1.4. Micro Ultrasound Systems
    - 9.3.2.1.5. Micro CT Systems
    - 9.3.2.1.6. Photoacoustic Imaging Systems
    - 9.3.2.1.7. Magnetic Particle Imaging Systems
  - 9.3.2.2. Reagents
    - 9.3.2.2.1. Preclinical Optical Imaging Reagents
    - 9.3.2.2.2. Preclinical Nuclear Imaging Reagents
    - 9.3.2.2.3. Preclinical MRI Contrast Agents
    - 9.3.2.2.4. Preclinical CT Contrast Agents
    - 9.3.2.2.5. Software
- 9.3.3. Market Attractiveness Analysis: Product Type
9.4. East Asia Preclinical Imaging Market Outlook: Application
- 9.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 9.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 9.4.2.1. Research and Development
  - 9.4.2.2. Drug Discovery
- 9.4.3. Market Attractiveness Analysis
9.5. East Asia Preclinical Imaging Market Outlook: End-user
- 9.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 9.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 9.5.2.1. Pharmaceutical & Biotechnology Companies
  - 9.5.2.2. Academic and research centres
  - 9.5.2.3. Imaging Centres
  - 9.5.2.4. Other End-users
- 9.5.3. Market Attractiveness Analysis: End-user
9.6. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 10.1.1. By Country
- 10.1.2. By Product Type
- 10.1.3. By Source
- 10.1.4. By Category
- 10.1.5. By Distribution Channel
10.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 10.2.1. India
- 10.2.2. Southeast Asia
- 10.2.3. ANZ
- 10.2.4. Rest of South Asia & Oceania
10.3. South Asia & Oceania Preclinical Imaging Market Outlook: Product Type
- 10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 10.3.2.1. Imaging Systems
    - 10.3.2.1.1. Optical Imaging Systems
    - 10.3.2.1.2. Nuclear Imaging Systems
    - 10.3.2.1.3. Micro MRI Systems
    - 10.3.2.1.4. Micro Ultrasound Systems
    - 10.3.2.1.5. Micro CT Systems
    - 10.3.2.1.6. Photoacoustic Imaging Systems
    - 10.3.2.1.7. Magnetic Particle Imaging Systems
  - 10.3.2.2. Reagents
    - 10.3.2.2.1. Preclinical Optical Imaging Reagents
    - 10.3.2.2.2. Preclinical Nuclear Imaging Reagents
    - 10.3.2.2.3. Preclinical MRI Contrast Agents
    - 10.3.2.2.4. Preclinical CT Contrast Agents
    - 10.3.2.2.5. Software
10.4. South Asia & Oceania Preclinical Imaging Market Outlook: Application
- 10.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 10.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 10.4.2.1. Research and Development
  - 10.4.2.2. Drug Discovery
10.5. South Asia & Oceania Preclinical Imaging Market Outlook: End-user
- 10.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 10.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 10.5.2.1. Pharmaceutical & Biotechnology Companies
  - 10.5.2.2. Academic and research centres
  - 10.5.2.3. Imaging Centres
  - 10.5.2.4. Other End-users
10.6. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 11.1.1. By Country
- 11.1.2. By Product Type
- 11.1.3. By Application
- 11.1.4. By End-user
11.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 11.2.1. Brazil
- 11.2.2. Mexico
11.3. Latin America Preclinical Imaging Market Outlook: Product Type
- 11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 11.3.2.1. Imaging Systems
    - 11.3.2.1.1. Optical Imaging Systems
    - 11.3.2.1.2. Nuclear Imaging Systems
    - 11.3.2.1.3. Micro MRI Systems
    - 11.3.2.1.4. Micro Ultrasound Systems
    - 11.3.2.1.5. Micro CT Systems
    - 11.3.2.1.6. Photoacoustic Imaging Systems
    - 11.3.2.1.7. Magnetic Particle Imaging Systems
  - 11.3.2.2. Reagents
    - 11.3.2.2.1. Preclinical Optical Imaging Reagents
    - 11.3.2.2.2. Preclinical Nuclear Imaging Reagents
    - 11.3.2.2.3. Preclinical MRI Contrast Agents
    - 11.3.2.2.4. Preclinical CT Contrast Agents
    - 11.3.2.2.5. Software
11.4. Latin America Preclinical Imaging Market Outlook: Application
- 11.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 11.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 11.4.2.1. Research and Development
  - 11.4.2.2. Drug Discovery
11.5. Latin America Preclinical Imaging Market Outlook: End-user
- 11.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 11.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 11.5.2.1. Pharmaceutical & Biotechnology Companies
  - 11.5.2.2. Academic and research centres
  - 11.5.2.3. Imaging Centres
  - 11.5.2.4. Other End-users
11.6. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Outlook: Historical (2019-2023) and Forecast (2024-2031)

12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 12.1.1. By Country
- 12.1.2. By Product Type
- 12.1.3. By Application
- 12.1.4. By End-user
12.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 12.2.1. GCC
- 12.2.2. South Africa
- 12.2.3. Northern Africa
12.3. Middle East & Africa Preclinical Imaging Market Outlook: Product Type
- 12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
  - 12.3.2.1. Imaging Systems
    - 12.3.2.1.1. Optical Imaging Systems
    - 12.3.2.1.2. Nuclear Imaging Systems
    - 12.3.2.1.3. Micro MRI Systems
    - 12.3.2.1.4. Micro Ultrasound Systems
    - 12.3.2.1.5. Micro CT Systems
    - 12.3.2.1.6. Photoacoustic Imaging Systems
    - 12.3.2.1.7. Magnetic Particle Imaging Systems
  - 12.3.2.2. Reagents
    - 12.3.2.2.1. Preclinical Optical Imaging Reagents
    - 12.3.2.2.2. Preclinical Nuclear Imaging Reagents
    - 12.3.2.2.3. Preclinical MRI Contrast Agents
    - 12.3.2.2.4. Preclinical CT Contrast Agents
    - 12.3.2.2.5. Software
12.4. Middle East & Africa Preclinical Imaging Market Outlook: Application
- 12.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 12.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
  - 12.4.2.1. Research and Development
  - 12.4.2.2. Drug Discovery
12.5. Middle East & Africa Preclinical Imaging Market Outlook: End-user
- 12.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 12.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
  - 12.5.2.1. Pharmaceutical & Biotechnology Companies
  - 12.5.2.2. Academic and research centres
  - 12.5.2.3. Imaging Centres
  - 12.5.2.4. Other End-users
12.6. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.2.3. Tier Structure Analysis
- 13.2.4. Regional Presence Analysis
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Bruker Corporation
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Products
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Siemens A.G.
- 13.3.3. General Electric (GE)
- 13.3.4. TriFoil Imaging
- 13.3.5. PerkinElmer, Inc.
- 13.3.6. VisualSonics Inc.(Fujifilm)
- 13.3.7. Mediso Ltd.
- 13.3.8. Agilent Technologies
- 13.3.9. MILabs B.V.
- 13.3.10. MR Solutions
- 13.3.11. Molecubes

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations